On behalf of Retina Action, Retina International would like to welcome you to the Diabetes-related Eye Diseases (DEDs) Toolkit. This educational resource was designed by patients for patients, their representatives and healthcare professionals concerned with vision health and avoidable blindness.
The objective of this toolkit is to give you an overview about DEDs, beginning with descriptions of Type 1, Type 2 and Gestational Diabetes and how management of these conditions can impact on eye health. This tool kit provides information on eye care and support with diabetes, coping with diagnosis of a diabetes-related eye condition, the role of the optometrist and ophthalmologist in management of your eye health as a person with diabetes, the importance of frequent screening, and descriptions of conditions your eye as a patient with diabetes will be more susceptible to.
DEDs are a collection of eye conditions that people living with diabetes are vulnerable to including the most sight threatening Diabetes-related Retinopathy and Diabetes-related Macular Edema. This tool kit also provides information on other conditions that people living with diabetes are much more vulnerable to such as Diabetes-related Glaucoma, Diabetes-related Cataract, Diabetes-related Keratopathy, Diabetes-related Dry Eye Syndrome, and Diabetes-related Uveitis.
Diabetes-related Retinopathy is the leading cause of blindness in the working population. Globally 145 million people have some form of Diabetes-related Retinopathy with 45 million of these affected by vision-threatening Diabetes-related Retinopathy. Sight loss due to Diabetes-related Retinopathy cannot be regained. Fortunately with appropriate diabetes management, screening and therapy the effects of diabetes on the eyes can be delayed and prevented. This toolkit provides detailed information on these points.
With increasing evidence that management of diabetes, implementation of screening programmes and timely diagnosis can reduce the severity of DEDs, coupled with the thousands of ongoing clinical trials continuously advancing therapies, it is important to spread awareness of the potential to maintain healthy diabetes-related eyes and preserve sight.
We hope that this toolkit is useful for you and look forward to your feedback and suggestions.